depression

Triangle biotech startup focusing on depression disorder raises $45M

Posted by WRAL TechWire | Nov 29, 2023

Arrivo BioVentures, which emerged from stealth mode less than two years ago with $49 million in funding and four drug candidates, has raised another $45 million and plans to advance its treatment focused on major depression disorder or MDD.

Drug ‘Special K’ cousin secures FDA approval to treat depression

Posted by WRAL TechWire | Mar 6, 2019

The US Food and Drug Administration approved Janssen Pharmaceuticals Inc.’s esketamine on Tuesday for treatment-resistant depression; the drug is the chemical cousin of ketamine, the powerful anesthetic that has been used illegally as the club drug Special K.

depression

Triangle biotech startup focusing on depression disorder raises $45M

Drug ‘Special K’ cousin secures FDA approval to treat depression

Categories

Tags